| Identification | Back Directory | [Name]
2-Propen-1-one, 3-[5-[(2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-1-(1-piperazinyl)-, (2E)- | [CAS]
1940165-80-9 | [Synonyms]
Boditrectinib
2-Propen-1-one, 3-[5-[(2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-1-(1-piperazinyl)-, (2E)- | [Molecular Formula]
C23H24F2N6O | [MOL File]
1940165-80-9.mol | [Molecular Weight]
438.47 |
| Hazard Information | Back Directory | [Uses]
Boditrectinib is a potent tyrosine kinase inhibitor. Boditrectinib serves as an antineoplastic agent. Boditrectinib is useful in the research of cancer, inflammation, neurodegenerative diseases and certain infectious diseases[1][2]. | [References]
[1] Kim Moonsoo, et al. Preparation of fused ring heteroaryl compounds and their use as Trk inhibitors: United States, US20160168156. 2016-06-16.
[2] WHO Drug Information-World Health Organization (WHO). |
|
|